Table 1.
Receptors | TLR1 | TLR2 | TLR3 | TLR4 | TLR5 | TLR6 | TLR7 | TLR8 | TLR9 | TLR10 | NOD1 | NOD2 | NL-RP3 | RIG1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Activated by: | Lipo-peptides |
Gram-PGN, LTA
& HSP, HMGB1 |
ds-RNA, polyI:C,
DAMP |
Gram+
LPS & HSP, HMGB1 |
Flagellin | LTA, lipopeps | ss-RNA |
ss-
RNA & pyogenic Bacteria |
CpG DNA
& mtDNA |
Retroviral RNA | Meso-DAP | MDP | ? | Viral RNA |
COVID-19 SEVERE | - | ^ | +/- | ^ | - | - | ^ | - | +/- | - | - | - | ^ | - |
INFLUENZA-ASSOCIATED ALI/ARDS | v | ^ | ^ | ^ | - | ^ | +/- | ^ | ^ | v | ||||
SEPSIS/ALI (murine) | ^ | +/- | ^ | - | ^ | ^ | - | - | ^ | |||||
SEPSIS human patients | - | +/- | - | ^ | +/- | - | +/- | - | -/v | - | - | - | ^ | |
Polymicrobial SEPSIS murine model | - | ^ | - | ^ | - | - | ^ | - | - | - | - | ^ | ||
SEPSIS CONCENSUS | - | ^ | - | ^ | - | - | ^ | - | - | - | - | ^ |